MYH14 and Sepsis: In CIM there is a greater loss of type 2 over type 1 fibres, and the preferential loss of myosin and myosin-related proteins relative to actin; the latter is a feature that is unique to CIM compared with other acquired causes (e.g. acute polyneuropathy or pure sepsis) of muscle weakness in critically ill patients.32